Healthcare
NASDAQ companies operating within the Healthcare sector, ranked by market capitalization.
| MLYS | NASDAQ | Mineralys Therapeutics, Inc. | $26.71 | -1.07% | 649K | $2.35B |
| CLDX | NASDAQ | Celldex Therapeutics, Inc. | $34.58 | -3.03% | 639K | $2.35B |
| ANAB | NASDAQ | AnaptysBio, Inc. | $54.15 | -1.38% | 487K | $2.34B |
| VCEL | NASDAQ | Vericel Corporation | $45.03 | -2.41% | 360K | $2.3B |
| KLRA | NASDAQ | Kailera Therapeutics, Inc. | $17.69 | +1.67% | 673K | $2.29B |
| CLOV | NASDAQ | Clover Health Investments, Corp. | $4.62 | +5.00% | 2.9M | $2.24B |
| IOVA | NASDAQ | Iovance Biotherapeutics, Inc. | $4.99 | -2.73% | 9.4M | $2.23B |
| LMAT | NASDAQ | LeMaitre Vascular, Inc. | $97.49 | -1.34% | 349K | $2.18B |
| ZLAB | NASDAQ | Zai Lab Limited | $19.22 | -2.34% | 478K | $2.17B |
| AGIO | NASDAQ | Agios Pharmaceuticals, Inc. | $36.36 | +0.22% | 890K | $2.16B |
| ADUS | NASDAQ | Addus HomeCare Corporation | $114.55 | +2.35% | 176K | $2.14B |
| IMNM | NASDAQ | Immunome, Inc. | $22.37 | -2.23% | 615K | $2.12B |
| SLS | NASDAQ | SELLAS Life Sciences Group, Inc. | $11.32 | -8.27% | 6.7M | $2.11B |
| AXGN | NASDAQ | AxoGen, Inc. | $39.49 | -0.60% | 751K | $2.1B |
| PLSE | NASDAQ | Pulse Biosciences, Inc. | $30.23 | -2.48% | 367K | $2.09B |
| HTFL | NASDAQ | Heartflow, Inc. Common Stock | $26.16 | -2.10% | 887K | $2.08B |
| SION | NASDAQ | Sionna Therapeutics, Inc. | $45.70 | +3.72% | 655K | $2.06B |
| AVAH | NASDAQ | Aveanna Healthcare Holdings Inc. | $9.45 | +4.07% | 3M | $2.06B |
| SGRY | NASDAQ | Surgery Partners, Inc. | $15.73 | +3.35% | 4.1M | $2.06B |
| AMLX | NASDAQ | Amylyx Pharmaceuticals, Inc. | $18.41 | +4.66% | 1.6M | $2.05B |
| NEOG | NASDAQ | Neogen Corporation | $9.40 | -2.19% | 1.2M | $2.05B |
| HRMY | NASDAQ | Harmony Biosciences Holdings, Inc. | $36.84 | -3.59% | 585K | $2.04B |
| NVCR | NASDAQ | Novocure Ltd | $17.65 | -11.71% | 3.9M | $2.04B |
| NBTX | NASDAQ | Nanobiotix S.A. | $39.42 | +10.33% | 104K | $2.01B |
| ASTH | NASDAQ | Astrana Health, Inc. | $40.99 | -2.27% | 442K | $2B |
| URGN | NASDAQ | UroGen Pharma Ltd. | $43.78 | +6.47% | 407K | $2B |
| MESO | NASDAQ | Mesoblast Limited | $16.22 | +5.05% | 188K | $1.99B |
| PVLA | NASDAQ | Palvella Therapeutics, Inc. | $144.76 | -4.16% | 184K | $1.98B |
| AUPH | NASDAQ | Aurinia Pharmaceuticals Inc. | $15.39 | +0.98% | 793K | $1.97B |
| RAPP | NASDAQ | Rapport Therapeutics, Inc. Common Stock | $40.68 | -1.69% | 270K | $1.95B |
| PGEN | NASDAQ | Precigen, Inc. | $5.40 | -2.53% | 2.9M | $1.93B |
| GLUE | NASDAQ | Monte Rosa Therapeutics, Inc. | $22.78 | -1.09% | 871K | $1.92B |
| HCM | NASDAQ | HUTCHMED (China) Limited | $11.01 | +0.46% | 51K | $1.92B |
| CDNA | NASDAQ | CareDx, Inc | $37.61 | -0.45% | 481K | $1.92B |
| ZBIO | NASDAQ | Zenas BioPharma, Inc. | $30.39 | -1.94% | 559K | $1.92B |
| ADMA | NASDAQ | ADMA Biologics, Inc. | $8.27 | -1.19% | 2.3M | $1.92B |
| GHRS | NASDAQ | GH Research PLC | $26.51 | -2.54% | 164K | $1.87B |
| MRVI | NASDAQ | Maravai LifeSciences Holdings, Inc. | $7.04 | +8.14% | 1.9M | $1.87B |
| OMCL | NASDAQ | Omnicell, Inc. | $41.00 | +2.86% | 567K | $1.86B |
| OCUL | NASDAQ | Ocular Therapeutix, Inc. | $8.71 | -2.90% | 1.2M | $1.86B |
| KARD | NASDAQ | Kardigan, Inc. | $20.74 | -4.29% | 158K | $1.85B |
| FTRE | NASDAQ | Fortrea Holdings Inc. | $19.52 | +0.10% | 1.3M | $1.85B |
| SNDX | NASDAQ | Syndax Pharmaceuticals, Inc. | $20.81 | -1.89% | 1.2M | $1.84B |
| UFPT | NASDAQ | UFP Technologies, Inc. | $237.20 | +0.42% | 191K | $1.84B |
| LKFT | NASDAQ | Lakefront Biotherapeutics N.V. | $27.84 | -1.00% | 167K | $1.83B |
| STOK | NASDAQ | Stoke Therapeutics, Inc. | $29.64 | +0.62% | 442K | $1.82B |
| TYRA | NASDAQ | Tyra Biosciences, Inc. | $32.13 | +1.65% | 638K | $1.82B |
| TSHA | NASDAQ | Taysha Gene Therapies, Inc. | $5.52 | -5.32% | 1.8M | $1.79B |
| IMCR | NASDAQ | Immunocore Holdings plc | $31.95 | -3.42% | 530K | $1.78B |
| ATRC | NASDAQ | AtriCure, Inc. | $35.04 | +6.18% | 1.7M | $1.77B |